0001799191-22-000056.txt : 20221208
0001799191-22-000056.hdr.sgml : 20221208
20221208190226
ACCESSION NUMBER: 0001799191-22-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221207
FILED AS OF DATE: 20221208
DATE AS OF CHANGE: 20221208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Virnich Daniel
CENTRAL INDEX KEY: 0001891107
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39248
FILM NUMBER: 221453458
MAIL ADDRESS:
STREET 1: C/O THE ONCOLOGY INSTITUTE OF HOPE
STREET 2: 18000 STUDEBAKER ROAD, SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncology Institute, Inc.
CENTRAL INDEX KEY: 0001799191
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
BUSINESS PHONE: 562-735-3226
MAIL ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
FORMER COMPANY:
FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP.
DATE OF NAME CHANGE: 20200108
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-12-07
0
0001799191
Oncology Institute, Inc.
TOI
0001891107
Virnich Daniel
C/O THE ONCOLOGY INSTITUTE INC.
18000 STUDEBAKER RD, SUITE 800
CERRITOS
CA
90703
0
1
0
0
President
Common Stock
2022-12-07
4
M
0
175000
0.86
A
448585
D
Common Stock
2022-12-07
4
M
0
175000
0.86
A
623585
D
Non-Qualified Stock Option (right to buy)
0.86
2022-12-07
4
M
0
175000
0.0
D
2030-03-01
Common Stock
175000
829609
D
Non-Qualified Stock Option (right to buy)
0.86
2022-12-07
4
M
0
175000
0.0
D
2030-03-01
Common Stock
175000
654609
D
These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.
These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.
By: Mark Hueppelsheuser For: Daniel Virnich
2022-12-08